Cargando…

Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients

OBJECTIVE: IgD multiple myeloma (MM) is a rare type of MM, accounting for about 1%–2% of all MMs. IgD MM always causes kidney damage and even leads to renal failure, which is the most common complication. This study aimed to explore the risk factors of renal damage and prognosis of IgD MM patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Ge, Li, Huangmin, Zhang, Yiding, Xia, Chenyan, Wang, Mengxiao, Jia, Yu, Shang, Jin, Zhao, Zhanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727151/ https://www.ncbi.nlm.nih.gov/pubmed/36505830 http://dx.doi.org/10.3389/fonc.2022.1012889

Ejemplares similares

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma
por: Wang, Wei, et al.
Publicado: (2018)

Anaplastic morphology in IgD multiple myeloma
por: Roldán Galiacho, Verónica, et al.
Publicado: (2023)

AL Amyloidosis in a Patient with IgD Myeloma
por: Rafik, Hicham, et al.
Publicado: (2020)

IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin.
por: Sewell, H. F., et al.
Publicado: (1986)

IgD Multiple Myeloma Paraproteinemia as a Cause of Myositis
por: Colombo, I., et al.
Publicado: (2010)

Aggressive FLC Escape in a Patient with IgD Myeloma
por: Farges, Cédric, et al.
Publicado: (2015)

Clinical characteristics and survival of patients with IgD multiple myeloma
por: Li, Yi, et al.
Publicado: (2021)

Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
por: De Santis, Elena, et al.
Publicado: (2016)

N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma
por: Chen, Jie, et al.
Publicado: (2017)

Diagnostic value of α1-MG and URBP in early diabetic renal impairment
por: Zhou, Yukun, et al.
Publicado: (2023)

The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients
por: Yao, Weiqin, et al.
Publicado: (2023)

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
por: Liu, Jin, et al.
Publicado: (2020)

Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas
Publicado: (1984)

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
por: Cheng, Qianwen, et al.
Publicado: (2021)

IgD myeloma indicated by plasma cells in the peripheral blood and massive pleural effusion
por: Natori, Kazuhiko, et al.
Publicado: (2008)

Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma
por: Kishi, Seiji, et al.
Publicado: (2018)

Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials
por: Agbuduwe, Charles, et al.
Publicado: (2022)

Expression of IgD by murine lymphocytes. Loss of surface IgD indicates maturation of memory B cells
Publicado: (1978)

Physiology of IgD. VI. Transfer of the immunoaugmenting effect of IgD with T delta-containing helper cell populations
Publicado: (1985)

IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy
por: Pisani, Francesco, et al.
Publicado: (2012)

Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review
por: Husnain, Muhammad, et al.
Publicado: (2016)

Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
por: Tsushima, Takafumi, et al.
Publicado: (2021)

Physiology of IgD. I. Compensatory phenomena in B lymphocyte activation in mice treated with anti-IgD antibodies
Publicado: (1981)

Frequency and Prognosis of Pulmonary Metastases in Newly Diagnosed Gastric Cancer
por: Sun, Zepang, et al.
Publicado: (2019)

Biclonal IgD and IgM Plasma Cell Myeloma: A Report of Two Cases and a Literature Review
por: Chen, Zhongchuan W., et al.
Publicado: (2013)

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
por: Wang, Peipei, et al.
Publicado: (2022)

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
por: Offidani, Massimo, et al.
Publicado: (2021)

The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
por: You, Hongying, et al.
Publicado: (2022)

IgD multiple myeloma with central nervous system involvement: A case report and literature review
por: Chen, Yi, et al.
Publicado: (2021)

Construction of a Nomogram Discriminating Malignancy-Associated Membranous Nephropathy From Idiopathic Membranous Nephropathy: A Retrospective Study
por: Wang, Ting, et al.
Publicado: (2022)

Teleost IgD(+)IgM(−) B Cells Mount Clonally Expanded and Mildly Mutated Intestinal IgD Responses in the Absence of Lymphoid Follicles
por: Perdiguero, Pedro, et al.
Publicado: (2019)

Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells
Publicado: (1993)

High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients
por: Dong, Mengmeng, et al.
Publicado: (2022)

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)
por: Jian, Yuan, et al.
Publicado: (2022)

Differential Expression of IgM and IgD Discriminates Two Subpopulations of Human Circulating IgM(+)IgD(+)CD27(+) B Cells That Differ Phenotypically, Functionally, and Genetically
por: Bautista, Diana, et al.
Publicado: (2020)

Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety
por: Zhai, Yujia, et al.
Publicado: (2021)

血清IgD定量检测在IgD型多发性骨髓瘤患者疗效评估中的价值
Publicado: (2016)

Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice
Publicado: (1977)

Teleost IgD(+)IgM(−) B cells in gills and skin have a plasmablast profile, but functionally and phenotypically differ from IgM(+)IgD(−) B cells in these sites
por: Herranz-Jusdado, J. Germán, et al.
Publicado: (2023)

Presentation Patterns, Diagnostic Markers, Management Strategies, and Outcomes of IgD Multiple Myeloma: A Systematic Review of Literature
por: Selene, Insija I, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uth0so3baqq12kgn98frr6jptb